Biosimilars Blog
RF 360

In the News

Insightful. Precise. Skilled.

LMG Life Sciences Names Attorneys 2017 Life Sciences Stars; Recognizes Firm for Hatch-Waxman Patent Litigation

October 9, 2017

Rothwell Figg is proud to announce that four partners – E. Anthony Figg, Steven Lieberman, Joseph A. Hynds, and R. Danny Huntington – have been named 2017 Life Sciences Stars in Intellectual Property by LMG Life Sciences. In addition to the individual attorney rankings, Rothwell Figg is listed as a “Recommended Firm” in the Hatch-Waxman Patent Litigation (Generic) area. LMG Life Sciences is a publication that compiles the leading firms and attorneys in the life sciences industry based on market feedback, independent research, client interviews, and peer opinions.

Since 2013, E. Anthony Figg has been recognized as a Star in the Intellectual Property practice area. Mr. Figg specializes in intellectual property law, primarily involving the chemical, pharmaceutical, health care, and biotechnology industries. His practice focuses on patent litigation and inter partes matters before the PTAB, appeals, ADR, patent procurement, intellectual property licensing and related contract matters, opinions, and counseling.

Steven Lieberman, also listed in the publication beginning in 2013, is recognized in the areas of General Patent Litigation, Patent Strategy & Management, and Hatch-Waxman Patent Litigation (Generic). Since 1991, Mr. Lieberman has litigated a variety of patent lawsuits in the pharmaceutical, biotech, veterinary, and medical products fields in both the district courts (and on appeal) and before the International Trade Commission. He also regularly advises clients on biosimilar issues and represents clients in IPR proceedings.

Joseph A. Hynds, recognized in the Intellectual Property practice area, has been practicing across the full spectrum of IP law at the firm for over 25 years, with a focus on patent infringement litigation. Mr. Hynds has particular expertise in Hatch-Waxman litigation and related issues, having litigated more than 50 Hatch-Waxman cases and in many, serving as lead trial counsel. He also has participated in numerous appeals to the U.S. Court of Appeals for the Federal Circuit. Mr. Hynds handles cases covering a broad range of pharmaceutical, medical device, biotechnology, and chemical technologies, among others.

Listed in the rankings since the inaugural edition in 2012, R. Danny Huntington is recognized in the areas of Patent Prosecution, General Patent Litigation, and Patent Strategy & Management. Mr. Huntington is involved in all phases of intellectual property law, including United States and foreign patent prosecution; litigation in the federal and state courts; licensing; and general client counseling. He has extensive patent interference experience, with particular experience in biotechnology and pharmaceuticals.

To learn more about LMG Life Sciences, and to view the full firm and attorney rankings, please visit